Breakthrough T1D Request for Applications: Accelerating the Development of Combined CGM–Pump Devices
Funds research to develop and clinically validate integrated CGM–pump devices for type 1 diabetes, overcoming technical, clinical, and translational barriers to accelerate real-world adoption.
Funder: Breakthrough T1D
Due Dates: September 2, 2026 (Letter of Intent) | November 4, 2026 (Full proposal)
Funding Amounts: Up to $900,000 total over 3 years; smaller budgets considered; indirect costs up to 10% for nonprofits.
Summary: Supports research to accelerate integrated CGM–pump device development for type 1 diabetes by addressing technical, clinical, and translational barriers.
Description
This opportunity funds research and development projects that advance the integration of continuous glucose monitoring (CGM) and insulin pump technologies into a single device to improve diabetes management for people with type 1 diabetes (T1D). The focus is on overcoming key technical, clinical, and translational challenges such as device compatibility, system reliability, manufacturing scalability, cost, and accessibility. Projects should prioritize the development, validation, and user-centered evaluation of combined CGM–pump devices, with an emphasis on collaborative, cross-disciplinary research that accelerates clinical translation and real-world adoption.
